Nektar Therapeutics reported $15.38M in Stock for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
ALKERMES ALKS:US $ 154.79M 4.45M
Amgen AMGN:US $ 4411M 325M
Baxter International BAX:US $ 2548M 95M
Biocryst Pharmaceuticals BCRX:US $ 16.14M 0.35M
Biogen BIIB:US $ 1215.4M 136.1M
Bristol Myers Squibb BMY:US $ 2104M 9M
Cara Therapeutics CARA:US 1.91M 677K
Eisai 4523:JP Y 99008M 6497M
Eli Lilly And LLY:US $ 3893M 7M
Esperion Therapeutics ESPR:US $ 35.65M 1.26M
Exelixis EXEL:US $ 28.47M 0.97M
Gilead Sciences GILD:US $ 2675M 1057M
GlaxoSmithKline GSK:LN 6003M 220M
Halozyme Therapeutics HALO:US $ 47.76M 6.15M
Karyopharm Therapeutics KPTI:US $ 3.87M 232K
Macrogenics MGNX:US $ 4.6M 0.21M
Merk MRK:US $ 5774M 179M
Nektar Therapeutics NKTR:US $ 15.38M 0.42M
Neurocrine Biosciences NBIX:US $ 29M 1.5M
Novartis NOVN:VX SF 6997M 331M
Pfizer PFE:US $ 9979M 920M
Sarepta Therapeutics SRPT:US $ 199M 12.78M
Seattle Genetics SGEN:US $ 275.75M 75.08M
Takeda 4502:JP Y 853167M 41843M
Teva Pharmaceutical TEVA:IT 4.01B 194M
YTE INCY:US $ 35.46M 7.55M